Bladder Cancer Clinical Trials
If you have been diagnosed with bladder cancer or are experiencing a recurrence, you’re likely feeling a swirl of emotions. Stress, fear, and confusion can be powerful forces, especially as you begin discussing treatment options with your doctor.
Today, there is something to be optimistic about. Bladder cancer clinical trials offer new treatment techniques that have the potential to be more effective than any existing treatment option.
By identifying the right bladder cancer clinical trial with your doctor and receiving innovative new therapies, you could improve your health outcomes and even avoid the negative side effects that often accompany traditional cancer treatments.
Clinical trials for bladder cancer emerge as first-choice treatments
Clinical trials are integral to the development of cancer treatments. We are fortunate to have access to effective cancer therapies today thanks to the many clinical trials that have taken place over the last decades.
However, until recently, many medical professionals only promoted clinical trials to their patients as a “last resort” option. Luckily, that perception has undergone remarkable progress in the last few years. Today, premier oncology organizations often recommend clinical trials as a first course of action for many patients.
Bladder cancer clinical trials — what do I need to know?
There are clinical trials for all types and stages of bladder cancer. People who participate in them can be among the first to receive breakthrough treatment.
The goal of bladder cancer clinical trials is to determine whether the experimental treatment is safe and potentially more effective than existing treatments. These studies examine new drugs, new combinations of existing treatments, new radiation therapy or surgical methods, or completely inventive means of treatment.
There are also clinical trials that are focused on relieving the symptoms and side effects of existing bladder cancer treatment, as well as managing the delayed effects that might occur a long time after the treatment has ended.
Your decision to join a bladder cancer clinical trial may be for any number of reasons. Some people, along with their doctors, might determine that a specific trial offers the best treatment option available. Others want to participate as a way to promote the progress of bladder cancer treatment.
Whatever reason you choose to search for bladder cancer clinical trials, make sure you leverage all the tools available to access the most personalized options for you. After answering a few questions about your diagnosis, TrialJectory uses artificial intelligence to match you with the trials that are right for you.
Bladder cancer clinical trials have introduced life-saving treatments
The success of bladder cancer clinical trials continues to benefit hundreds of thousands of patients around the world.
For example, Memorial Sloan Kettering Cancer Center, a leading academic medical center, led a clinical trial that developed immunotherapy drugs for advanced bladder cancer. Participants of that trial were among the first to receive atezolizumab (Tencentriq®), which subsequently became the first new FDA-approved drug for bladder cancer in over 20 years.
Another MSK clinical trial led to the approval of pembrolizumab (Keytruda®) for bladder cancer in 2017.